David Dai Score: 26
Avg Return (Buy)
How much profit would you make?
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
Calculates the average return of all BUY recommendations after exactly 1 year (or today if newer).
Note: Sell ratings are ignored here to focus on investment potential.
+1.7%
1 Year Cap
Win Rate
How often is the direction correct?
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
Percentage of trades that are currently profitable.
• Buy: Stock price went UP 📈
• Sell: Stock price went DOWN 📉
43%
9 W / 12 L
Target Met
How often was the target reached?
Hits vs. Total.
Hits vs. Total.
50%
8 W / 8 L
Precision Hit
How often precise (±3%)?
Hits vs. Total.
Hits vs. Total.
6%
1 W / 15 L
Bullseye Hit
How often perfect (±1%)?
Hits vs. Total.
Hits vs. Total.
6%
1 W / 15 L
High Conviction
The "Brave" Trades (>20% Upside)
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
Win Rate only for recommendations where the analyst predicted a massive move (>20%).
Shows if they are right when they bet big.
42%
8 W / 11 L
Long Wins
Success rate for BUY ratings
How often is the analyst right when saying "Buy"?
(Price went UP).
How often is the analyst right when saying "Buy"?
(Price went UP).
45%
9 W / 11 L
Short Wins
Success rate for SELL ratings
How often is the analyst right when saying "Sell"?
(Price went DOWN).
How often is the analyst right when saying "Sell"?
(Price went DOWN).
0%
0 W / 1 L
Coverage & Price Targets
| Date | Stock | Signal | Target | Start Price | Best Price (1Y) | Accuracy | Current Price |
|---|---|---|---|---|---|---|---|
| Jun 10, 2026 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$124.00
Est. +1%
|
$123.25 | $123.56 |
Bullseye Hit (±1%)
|
$123.25
0.0%
|
| Jun 09, 2026 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$23.00
Est. +53%
|
$15.07 | $18.91 |
Pending
|
$16.95
+12.5%
|
| May 18, 2026 |
Arm Holdings plc. - ADR
ARM
|
BUY |
$300.00
Est. +43%
|
$209.16 | $427.99 |
Target Met
|
$380.81
+82.1%
|
| Mar 13, 2026 |
Kura Oncology Inc
KURA
|
BUY |
$15.00
Est. +74%
|
$8.60 | $11.52 |
Pending
|
$9.05
+5.2%
|
| Jan 29, 2026 |
ASML Holding NV - New York Shares
ASML
|
BUY |
$1,911.00
Est. +34%
|
$1,422.92 | $1,903.47 |
Bullseye Hit (±1%)
|
$1,863.55
+31.0%
|
| Jan 22, 2026 |
ASML Holding NV - New York Shares
ASML
|
BUY |
$1,642.00
Est. +21%
|
$1,360.09 | $1,903.47 |
Target Met
|
$1,863.55
+37.0%
|
| Dec 02, 2025 |
Janux Therapeutics Inc
JANX
|
BUY |
$57.00
Est. +230%
|
$17.28 | $18.86 |
Pending
|
$13.56
-21.5%
|
| Oct 31, 2025 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$132.00
Est. +34%
|
$98.17 | $123.62 |
Pending
|
$123.25
+25.5%
|
| Jul 15, 2025 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$35.00
Est. +257%
|
$9.80 | $25.58 |
Pending
|
$18.25
+86.2%
|
| May 16, 2025 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$2.00
Est. +20%
|
$1.66 | $5.63 |
Target Met
|
$4.08
+145.8%
|
| Oct 24, 2024 |
Nurix Therapeutics Inc
NRIX
|
BUY |
$35.00
Est. +41%
|
$24.78 | $29.56 |
Miss
|
$16.95
-31.6%
|
| Oct 24, 2024 |
Syndax Pharmaceuticals Inc
SNDX
|
BUY |
$37.00
Est. +100%
|
$18.54 | $22.50 |
Miss
|
$18.25
-1.6%
|
| Oct 24, 2024 |
Ideaya Biosciences Inc
IDYA
|
BUY |
$50.00
Est. +69%
|
$29.50 | $32.67 |
Miss
|
$28.98
-1.8%
|
| Oct 24, 2024 |
Kura Oncology Inc
KURA
|
BUY |
$27.00
Est. +59%
|
$17.02 | $19.73 |
Miss
|
$9.05
-46.8%
|
| Oct 24, 2024 |
Janux Therapeutics Inc
JANX
|
BUY |
$69.00
Est. +33%
|
$51.75 | $71.71 |
Target Met
|
$13.56
-73.8%
|
| Oct 24, 2024 |
Cg Oncology Inc.
CGON
|
BUY |
$60.00
Est. +68%
|
$35.61 | $45.56 |
Miss
|
$59.56
+67.3%
|
| Oct 24, 2024 |
Perspective Therapeutics Inc
CATX
|
BUY |
$20.00
Est. +71%
|
$11.69 | $12.90 |
Miss
|
$2.95
-74.8%
|
| Oct 24, 2024 |
Nuvalent Inc - Ordinary Shares - Class A
NUVL
|
BUY |
$100.00
Est. +7%
|
$93.71 | $99.94 |
Bullseye Hit (±1%)
|
$123.25
+31.5%
|
| Oct 24, 2024 |
Iovance Biotherapeutics Inc
IOVA
|
BUY |
$17.00
Est. +73%
|
$9.82 | $12.50 |
Miss
|
$4.08
-58.5%
|
| Oct 24, 2024 |
Blueprint Medicines Corp
BPMC
|
BUY |
$88.00
Est. +4%
|
$84.40 | $129.65 |
Target Met
|
$129.46
+53.4%
|
| Oct 24, 2024 |
Merus N.V
MRUS
|
BUY |
$72.00
Est. +38%
|
$52.31 | $95.06 |
Target Met
|
$90.00
+72.1%
|
| Oct 24, 2024 |
Cullinan Therapeutics Inc
CGEM
|
BUY |
$30.00
Est. +92%
|
$15.61 | $17.50 |
Miss
|
$13.70
-12.2%
|
| Oct 24, 2024 |
Immunocore Holdings plc - ADR
IMCR
|
SELL |
$24.00
Est. +25%
|
$32.02 | $23.15 (Low) |
Target Met
|
$28.96
+9.6%
|
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Jun 10, 2026
Signal & Target
BUY
$124.00
Start Price
$123.25
Best Price (1Y)
$123.56
Current Price
$123.25
Return
0.0%
Nurix Therapeutics Inc
NRIX
Jun 09, 2026
Signal & Target
BUY
$23.00
Start Price
$15.07
Best Price (1Y)
$18.91
Current Price
$16.95
Return
+12.5%
Arm Holdings plc. - ADR
ARM
May 18, 2026
Signal & Target
BUY
$300.00
Start Price
$209.16
Best Price (1Y)
$427.99
Current Price
$380.81
Return
+82.1%
Kura Oncology Inc
KURA
Mar 13, 2026
Signal & Target
BUY
$15.00
Start Price
$8.60
Best Price (1Y)
$11.52
Current Price
$9.05
Return
+5.2%
ASML Holding NV - New York Shares
ASML
Jan 29, 2026
Signal & Target
BUY
$1,911.00
Start Price
$1,422.92
Best Price (1Y)
$1,903.47
Current Price
$1,863.55
Return
+31.0%
ASML Holding NV - New York Shares
ASML
Jan 22, 2026
Signal & Target
BUY
$1,642.00
Start Price
$1,360.09
Best Price (1Y)
$1,903.47
Current Price
$1,863.55
Return
+37.0%
Janux Therapeutics Inc
JANX
Dec 02, 2025
Signal & Target
BUY
$57.00
Start Price
$17.28
Best Price (1Y)
$18.86
Current Price
$13.56
Return
-21.5%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Oct 31, 2025
Signal & Target
BUY
$132.00
Start Price
$98.17
Best Price (1Y)
$123.62
Current Price
$123.25
Return
+25.5%
Syndax Pharmaceuticals Inc
SNDX
Jul 15, 2025
Signal & Target
BUY
$35.00
Start Price
$9.80
Best Price (1Y)
$25.58
Current Price
$18.25
Return
+86.2%
Iovance Biotherapeutics Inc
IOVA
May 16, 2025
Signal & Target
BUY
$2.00
Start Price
$1.66
Best Price (1Y)
$5.63
Current Price
$4.08
Return
+145.8%
Nurix Therapeutics Inc
NRIX
Oct 24, 2024
Signal & Target
BUY
$35.00
Start Price
$24.78
Best Price (1Y)
$29.56
Current Price
$16.95
Return
-31.6%
Syndax Pharmaceuticals Inc
SNDX
Oct 24, 2024
Signal & Target
BUY
$37.00
Start Price
$18.54
Best Price (1Y)
$22.50
Current Price
$18.25
Return
-1.6%
Ideaya Biosciences Inc
IDYA
Oct 24, 2024
Signal & Target
BUY
$50.00
Start Price
$29.50
Best Price (1Y)
$32.67
Current Price
$28.98
Return
-1.8%
Kura Oncology Inc
KURA
Oct 24, 2024
Signal & Target
BUY
$27.00
Start Price
$17.02
Best Price (1Y)
$19.73
Current Price
$9.05
Return
-46.8%
Janux Therapeutics Inc
JANX
Oct 24, 2024
Signal & Target
BUY
$69.00
Start Price
$51.75
Best Price (1Y)
$71.71
Current Price
$13.56
Return
-73.8%
Cg Oncology Inc.
CGON
Oct 24, 2024
Signal & Target
BUY
$60.00
Start Price
$35.61
Best Price (1Y)
$45.56
Current Price
$59.56
Return
+67.3%
Perspective Therapeutics Inc
CATX
Oct 24, 2024
Signal & Target
BUY
$20.00
Start Price
$11.69
Best Price (1Y)
$12.90
Current Price
$2.95
Return
-74.8%
Nuvalent Inc - Ordinary Shares - Class A
NUVL
Oct 24, 2024
Signal & Target
BUY
$100.00
Start Price
$93.71
Best Price (1Y)
$99.94
Current Price
$123.25
Return
+31.5%
Iovance Biotherapeutics Inc
IOVA
Oct 24, 2024
Signal & Target
BUY
$17.00
Start Price
$9.82
Best Price (1Y)
$12.50
Current Price
$4.08
Return
-58.5%
Blueprint Medicines Corp
BPMC
Oct 24, 2024
Signal & Target
BUY
$88.00
Start Price
$84.40
Best Price (1Y)
$129.65
Current Price
$129.46
Return
+53.4%
Merus N.V
MRUS
Oct 24, 2024
Signal & Target
BUY
$72.00
Start Price
$52.31
Best Price (1Y)
$95.06
Current Price
$90.00
Return
+72.1%
Cullinan Therapeutics Inc
CGEM
Oct 24, 2024
Signal & Target
BUY
$30.00
Start Price
$15.61
Best Price (1Y)
$17.50
Current Price
$13.70
Return
-12.2%
Immunocore Holdings plc - ADR
IMCR
Oct 24, 2024
Signal & Target
SELL
$24.00
Start Price
$32.02
Best Price (1Y)
$23.15
Current Price
$28.96
Return
+9.6%